Abstract

The management of pediatric bronchial asthma is often addressed by emergency department (ED) personnel. By surveying emergency program directors, we identify prevailing methods of albuterol delivery for the treatment of an acute asthma exacerbation. Because the Cochrane systematic review reports an equivalent effectiveness of the nebulizer versus metered dose inhaler (MDI) with valved holding chambers (VHC) for albuterol delivery, one might surmise that their usage would be evenly split. However, we find that within an ED setting, use of MDI with VHC sans nebulizer for acute asthma exacerbation is seldom used: 0–1% across all age groups. This is even more surprising considering the nebulizer has been shown to be more expensive than MDI with VHC. It stands to reason the promotion of national guidelines would result in potential cost savings. (Pediatr Asthma Allergy Immunol 2006; 19[3]:180–184).

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.